25421 postsback to top Posted 8 months ago FDA approves less-
invasive heart defibrillator Implantable defibrillators use thin
wires to send electrical signals that disrupt dangerous heart
rhythms. Surgeons have traditionally connected the wires to the
heart through a blood vessel in the upper chest. The new device
from Boston Scientific uses wires that sit just below the skin's
surface and do not need to be threaded through the heart's blood
vessels. Natick, Mass.-based Boston Scientific Corp. acquired
the device through a $150 million buyout of San Clemente,
Calif.-based Cameron Health. Under the terms of the deal, Boston
Scientific will pay an additional $150 million for FDA approval,
plus up to $1 billion in payments based on future sales figures.